|2.||Acquired Immunodeficiency Syndrome (AIDS)
|1.||Abe, Shigeru: 18 articles (01/2015 - 08/2003)|
|2.||Hayama, Kazumi: 10 articles (01/2015 - 01/2010)|
|3.||Ishibashi, Hiroko: 9 articles (03/2012 - 08/2003)|
|4.||Worthington, H V: 8 articles (01/2007 - 01/2000)|
|5.||Clarkson, J E: 8 articles (01/2007 - 01/2000)|
|6.||Eden, O B: 7 articles (01/2007 - 01/2000)|
|7.||Ninomiya, Kentaro: 5 articles (01/2014 - 01/2012)|
|8.||Ashman, R B: 5 articles (02/2009 - 12/2001)|
|9.||Kaomongkolgit, Ruchadaporn: 4 articles (11/2015 - 09/2009)|
|10.||Takahashi, Miki: 4 articles (01/2015 - 01/2012)|
|1.||Fluconazole (Zonal)FDA LinkGeneric
01/01/2009 - "Determination of the amount of drug released in saliva after application of the selected fluconazole films confirmed the ability of the film to deliver the drug over a period of approximately 300 minutes and to reduce side effects and possibility of drug interaction encountered during systemic therapy of fluconazole, which would be beneficial in the case of oral candidiasis."
01/01/2008 - "Determination of the amount of drug released in saliva after application of the selected fluconazole disc confirmed the ability of the disc to deliver the drug over a period of approximately 5 h and to reduce side effects and possibility of drug interaction encountered during systemic therapy of fluconazole, which would be beneficial in the case of oral candidiasis."
06/01/2002 - "The purpose of the present study was to evaluate the clinical efficacy of fluconazole aqueous mouthrinses to treat oral candidiasis. "
03/05/1998 - "Limited pharmacokinetic samples were taken on days 1 and 7. Of 26 evaluable patients, 16 showed partial improvement, nine showed no improvement, and only one had full clearance of thrush by day 7. In vitro testing of the cleared patient's isolate suggested that it was susceptible to fluconazole. "
07/01/2002 - "This study aimed to test the MICs (minimal inhibitory concentrations) to fluconazole of Candida species isolated from mouthwash specimens of 54 HIV positive patients with oral candidiasis. "
|2.||Nystatin (Mycostatin)FDA LinkGeneric
08/15/1996 - "In this small group of subjects, nystatin appeared to be effective in delaying onset of oral candidiasis. "
08/30/1986 - "Efficacy of a new nystatin formulation in oral candidiasis."
06/28/1986 - "Assessment of oral candidiasis in patients with respiratory disease and efficacy of a new nystatin formulation."
07/01/2010 - "SISA topical application, shows a comparable efficacy to the nystatin in the management of chronic oral candidiasis. "
01/01/1981 - "A human study of the effects of topical nystatin (Mycostatin) therapy of oral candidiasis showed that effects of treatment were limited to the time in which the drug was used. "
|3.||Clotrimazole (Lotrimin)FDA LinkGeneric
11/30/1978 - "We conclude that clotrimazole is highly effective treatment for chronic oral candidiasis."
03/01/2015 - "The novel clotrimazole sustained release varnish may be an important part of a new protocol for oral candidiasis, with improved clinical outcomes."
03/01/2015 - "Comparison of the efficacy of a novel sustained release clotrimazole varnish and clotrimazole troches for the treatment of oral candidiasis."
02/01/1984 - "Clotrimazole troches are effective in preventing oral candidiasis in a select group of patients."
03/01/2015 - "The aim of this study was to compare the efficacy of this varnish with clotrimazole troche treatment of oral candidiasis. "
|4.||Amphotericin B (Amphotericin)FDA LinkGeneric
01/01/2012 - "The significant variation in amphotericin B-induced PAFE amongst different Candida species may have clinical implications in terms of amphotericin B regimens used in the management of oral candidiasis."
01/01/2008 - "A diagnosis of oral candidiasis was made through positive KOH direct microscopic examination and he was instructed to rinse his oral mucosal lesion with amphotericin B syrup. "
09/01/2002 - "This report demonstrates the potential role for topical amphotericin B in the treatment of azole-refractory oral candidiasis. "
01/01/2001 - "This group at high risk of developing oral candidiasis should gargle with amphotericin B at concentrations higher than 100 times dilution that can prevent clinically detectable oral candidiasis."
12/01/1996 - "Orally administered amphotericin B in the treatment of oral candidiasis in HIV-infected patients caused by azole-resistant Candida albicans."
|5.||Ketoconazole (Nizoral)FDA LinkGeneric
07/01/1980 - "All thrush lesions were clinically and mycologically cured within a few days of treatment with 100-400 micrograms of ketoconazole daily; skin lesions were cured within a few weeks, and nails were cured after about three months of treatment. "
01/01/2010 - "A drug absorbed from the GI tract, ketoconazole, was more beneficial than placebo in eradicating oral candidiasis (one trial: RR = 3.61, 95% CI 1.47 to 8.88). "
09/01/2006 - "A prospective study to identify clinical and mycological aspects of oral candidiasis including a therapeutic trial for 4 drugs-2 topical (chlotrimazole and nistatine) and 2 systemic (itraconale and ketoconazole) was performed on 97 HIV adult patients from March 2003 to June 2004. "
07/01/1997 - "Ketoconazole resistant oral candidiasis in HIV-infected patients."
10/01/1996 - "Eighty-five consecutively seen HIV-positive persons with oral candidiasis were evaluated for clinical characteristics, staging of HIV disease, quantitation of candidal colony formation, and response to systemic antifungal treatment with Nizoral (ketoconazole). "
|6.||Itraconazole (Sporanox)FDA LinkGeneric
05/01/1998 - "Treatment of thrush with itraconazole solution: evidence for topical effect."
11/01/1997 - "Pharmacokinetics of itraconazole (oral solution) in two groups of human immunodeficiency virus-infected adults with oral candidiasis."
11/01/2000 - "A 70-year-old woman had erythema, oedema and vesicles on sun-exposed areas after 5 days of itraconazole treatment for oral candidiasis. "
02/01/2007 - "Oral administration of itraconazole OS at doses of 0.8, 4.0 or 20 mg/kg/day clearly decreased the number of viable Candida albicans cells in the oral cavity of mice with oral candidiasis in a dose-dependent manner at 3 days after infection. "
05/01/1997 - "The successful treatment of oral candidiasis (thrush) in a pediatric patient using itraconazole."
01/01/2000 - "A marked decrease of minor and major OI was observed and clinical resistance of thrush to antifungal agents became extremely rare. "
01/01/2015 - "In view of the limitations of antifungal agents used in the treatment of oral candidiasis and the wide variety of natural products that have been studied as treatment of this disease, this systematic literature review proposed to evaluate whether scientific evidence attesting to the efficacy of natural products in the treatment of this disease exists. "
01/01/2014 - "The isolation frequency and susceptibility to antifungal agents of oral Candida isolates from patients with oral candidiasis (OC) were compared between studies conducted in 2006-2007 and 2012-2013. "
04/01/2015 - "The use of probiotics may be an alternative approach to antifungal agents in the prevention and treatment of oral candidiasis. "
01/01/2015 - "Limitations of antifungal agents used in the treatment of oral candidiasis, as the development of resistant strains, are known by the scientific community. "
|8.||Miconazole (Monistat)FDA LinkGeneric
09/01/2009 - "Miconazole is effective against oral thrush."
03/01/1996 - "In a prospective open randomized multicentre study involving 12 paediatricians in private practice, Candio-Hermal and Lederlind were compared with miconazole oral gel (Daktar, Janssen) in 95 infants with oral thrush (candidosis). "
08/07/2004 - "A 17-day-old female infant with thrush was almost asphyxiated by miconazole oral gel that had been applied to the nipples of her mother's breasts. "
10/09/2000 - "Her daily maintenance dose was 5 mg. Monthly measurements of international normalised ratio (INR) were stable between 2-3. She developed oral candidiasis and miconazole gel was prescribed. "
10/01/1980 - "Miconazole gel for the treatment of oral thrush in adult patients."
05/01/2005 - "In 3 cases, all with thrush isolated to the vocal folds, inhaled steroids were the only causative factor identifiable--a feature reported only twice previously. "
06/01/2003 - "Fungal culture of a retropharyngeal wall swab may be useful for predicting the risk of developing oral candidiasis in asthmatic patients treated with inhaled steroids. "
07/01/2000 - "Occurrence and risk factors of oral candidiasis treated with oral antifungals in seniors using inhaled steroids."
05/01/1998 - "Inhaled steroids and oral candidiasis. "
10/01/1986 - "Oral topical steroids and secondary oral candidiasis."
01/01/2008 - "Interestingly, presence of co-existent oral candidiasis nullified these changes."
04/26/2004 - "[For oral candidiasis and co. "
03/01/1998 - "Their roles as predictors warrant further study, based on their associations with low CD4 cell counts and AIDS and strong co-prevalence with one of the most common HIV-related oral lesions, oral candidiasis."
02/01/2014 - "S. oralis and C. albicans co-infection significantly augmented the frequency and size of oral thrush lesions. "
06/01/2014 - "Role of oral candidiasis in TB and HIV co-infection: AIDS Clinical Trial Group Protocol A5253."
|1.||Highly Active Antiretroviral Therapy (HAART)
01/01/2006 - "These findings indicate that HAART is highly effective in decreasing oral candidiasis in association with a rise in CD4+ lymphocyte counts, but only marginally effective in eliminating Candida from the oropharynx."
02/01/2015 - "This systematic review clarifies the role of oral candidiasis in the HAART era as a marker of immune status and successful therapy for the HIV-infected population."
01/01/2006 - "This study is to determine the effect of prolonged highly active antiretroviral therapy (HAART) on oropharyngeal colonization with Candida species and oral candidiasis. "
08/01/2015 - "Oral candidiasis is still frequent in HIV-positive children in the highly active antiretroviral therapy era irrespective of geographical location, race and use of antiretroviral therapy. "
08/01/2015 - "Prevalence of oral candidiasis varied from 2.9% in American HIV-positive children undergoing highly active antiretroviral therapy to 88% in Chilean HIV-positive children without antiretroviral therapy. "
|2.||Drug Therapy (Chemotherapy)
05/01/2001 - "The case-control study revealed an increased risk of EC in patients with a recent low CD4+ cell count (P < 0.0002), recent antibacterial chemotherapy (P = 0.01) and oral candidiasis (P < 0.05). "
04/01/1995 - "[Oral candidiasis: diagnosis and drug therapy]."
01/01/2014 - "Oral candidiasis is particularly evident, not only in cancer patients receiving chemotherapy, but also in elderly people with xerostomy. "
10/01/2006 - "Palatal yeast carriage was significantly increased in thrush and denture stomatitis, also after radiation, chemotherapy and denture wearing. "
09/01/2002 - "Both suffered from recurrent oral candidiasis after a thymectomy, radiotherapy, and chemotherapy. "
11/01/2004 - "The increased incidence of oral candidiasis in patients with malignancies stems partly from the systemic disease itself and, partly from the therapeutic measures such as cytotoxic and other immunosuppressive drugs and radiotherapy they receive during management of such malignancies. "
11/01/2004 - "Cytotoxic drugs, radiotherapy and oral candidiasis."
01/01/1959 - "Thrush complicating radiotherapy of the mouth and neck."
08/01/2012 - "Herein the author postulates that oral Aloe vera mouthwash may not only prevent radiation-induced mucositis by its wound healing and antiinflammatory mechanism, but also may reduce oral candidiasis of patients undergoing head and neck radiotherapy due to its antifungal and immunomodulatory properties. "
09/01/2010 - "Patients undergoing radiotherapy for head and neck cancer are at increased risk of developing oral candidiasis and they more frequent have prior fungi colonization. "
|4.||Oral Hygiene (Dental Hygiene)
01/01/2008 - "Duration of therapy and oral hygiene were the variables associated with the presence of oral candidiasis."
01/01/2008 - "Data with respect to demographics, treatment type and duration, clinical laboratory results for blood leucocytes, oral hygiene, and diagnosis of oral candidiasis were collected. "
06/01/2007 - "Caries and oral candidiasis are correlated with the reduced secretion of saliva and with poor oral hygiene. "
04/01/2002 - "RTPs who used a chewing stick (Miswak: Salvadora persica ) for oral hygiene had a significantly lower prevalence of oral candidiasis (P =.04) compared with other RTPs. "
07/01/2013 - "The study assessed oral hygiene habits, systemic pathology, type of drugs used and the duration of use, oral pathology, oral health indices, risk of caries based on saliva tests, oral candidiasis and periodontal microbiology. "
|5.||Photochemotherapy (Photodynamic Therapy)
08/01/2012 - "Antimicrobial photodynamic therapy in the treatment of oral candidiasis in HIV-infected patients."
02/01/2002 - "These results suggest that MB-mediated photodynamic therapy can potentially be used to treat oral candidiasis in immunodeficient patients."
02/01/2002 - "The purpose of this study was to evaluate the efficacy of using methylene blue (MB)-mediated photodynamic therapy to treat oral candidiasis in an immunosuppressed murine model, mimicking what is found in human patients. "
02/01/2002 - "Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model."
01/01/2010 - "This chapter will focus on the use of PDT in the treatment of antibiotic-resistant biofilms, antibiotic-resistant wound infections, and azole-resistant oral candidiasis using methylene blue-based photodynamic therapy."